Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

NJ Innovation Institute’s Haro Hartounian to Moderate Industry Panel at Regional Pharma Manufacturing Expo on November 17

11/11/2016

0 Comments

 
Newark, NJ — Haro Hartounian Ph.D., executive director, bio-pharmaceutical cluster development at the New Jersey Innovation Institute (NJII) will moderate an industry panel focused on “The View Ahead” at the Regional Pharma Manufacturing Expo Nov. 17 at the DoubleTree Hotel, Somerset, New Jersey.
 
Panelists will include David Pollard, Ph.D., executive director of bioprocess technology & expression, bioprocess development, Merck; Joanne T. Beck, Ph.D. executive vice president, global pharmaceutical development & operations, Celgene and Ben Locwin, Ph.D., president, Healthcare Science Advisors.
 
While addressing unmet medical needs, pharmaceutical and biotech companies are facing a complex and challenging future. Technological advances in pharmaceutical and biologics manufacturing are stimulating new processes and opening new opportunities.
 
RPM Expo is a marketplace for manufacturing engineers, managers, and front line operators to meet with innovative and mature service companies. 
​In addition to manufacturing equipment makers, RPM Expo 2016 will bring together decision makers with the resources required to implement evolving solutions in this highly regulated environment.
 
The Expo is focused on today's most advanced strategies and technologies for manufacturing drugs reproducibly and cost-effectively.
 
In addition to his role as executive director for the biopharmaceutical iLab at NJII, Dr. Hartounian is an adjunct associate professor at Columbia' University's Chemical Engineering Department.
 
He was formerly the CEO and Co-Founder of DIAVACS, a clinical-stage biotechnology company whose mission is to treat auto-immune diseases, and he founded Allied Bioventures, a business advisory service working with companies in the life sciences industry.
 
Dr. Hartounian also serves as QED advisor for member companies in the University City Science Center. And he served as President and CEO of Vyteris, Inc. He was founder, director and CEO of Protagenic Therapeutics Inc., a biotechnology company created to develop treatments for neurological disorders.
 
Dr. Hartounian was also president and COO of Microislet, Inc., where he established Microislet as a major player in the field of cell therapy for treatment of Type 1 diabetes.
 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Powered by Create your own unique website with customizable templates.